The Marcus Corporation is an entertainment business based in the US. The Marcus Corporation shares (MCS) are listed on the NYSE and all prices are listed in US Dollars. The Marcus Corporation employs 1,680 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $16.68 |
|---|---|
| 52-week range | $14.42 - $24.71 |
| 50-day moving average | $18.22 |
| 200-day moving average | $18.45 |
| Wall St. target price | $26.50 |
| PE ratio | 27.8149 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.85 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $16.68 from 2022-01-24
| 1 week (2022-01-18) | -3.30% |
|---|---|
| 1 month (2021-12-23) | -6.92% |
| 3 months (2021-10-25) | -11.75% |
| 6 months (2021-07-23) | 3.80% |
| 1 year (2021-01-25) | -4.47% |
|---|---|
| 2 years (2020-01-24) | -44.27% |
| 3 years (2019-01-25) | 43.19 |
| 5 years (2017-01-25) | 30.95 |
Valuing The Marcus Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Marcus Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
The Marcus Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, The Marcus Corporation shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
The Marcus Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 21.4. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Marcus Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
The Marcus Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $44.9 million.
The EBITDA is a measure of a The Marcus Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $311 million |
|---|---|
| Gross profit TTM | $51.1 million |
| Return on assets TTM | -5.46% |
| Return on equity TTM | -1864.09% |
| Profit margin | -28.54% |
| Book value | $14.08 |
| Market capitalisation | $531.3 million |
TTM: trailing 12 months
We're not expecting The Marcus Corporation to pay a dividend over the next 12 months.
The Marcus Corporation's shares were split on a 3:2 basis on 7 December 1997. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your The Marcus Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for The Marcus Corporation shares which in turn could have impacted The Marcus Corporation's share price.
Over the last 12 months, The Marcus Corporation's shares have ranged in value from as little as $14.42 up to $24.71. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Marcus Corporation's is 1.8023. This would suggest that The Marcus Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. As of March 4, 2021, it owned or operated 1,097 screens at 89 movie theatre locations in 17 states under the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brands; and owned and managed 18 hotels, resorts, and other properties in 8 states. The company also operates a family entertainment center under the Funset Boulevard name in Appleton, Wisconsin, as well as owns and operates a retail outlet under the name of Ronnie's Plaza in St. Louis, Missouri. In addition, it provides hospitality management services, including check-in, housekeeping, and maintenance for a vacation ownership development. The company was founded in 1935 and is headquartered in Milwaukee, Wisconsin. .
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.